GlaxoSmithKline welcomes innovative knowledge-sharing collaboration to break deadlock in antibiotic discovery and development
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
List view / Grid view
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
15 November 2011 | By Amgen
The EC has approved a variation to the marketing authorization for Vectibix®...
3 October 2011 | By Ogilvy Healthworld UK Limited
Pfizer announce the launch of BeneFIX® with Room Temperature Storage (RTS)....
8 September 2011 | By Novartis
The European Commission has approved Votubia® (everolimus) tablets* for the treatment of patients aged 3 years and older...
5 September 2011 | By Novartis
The European Commission has approved Afinitor® (everolimus) tablets...
25 August 2011 | By Boehringer Ingelheim
Marketing Authorisation from the European Commission for Trajenta® (linagliptin)...
4 August 2011 | By Ogilvy Healthworld UK Limited
Pradaxa®1 (dabigatran etexilate) approved...
3 August 2011 | By Roche
The European Commission has approved the use of RoACTEMRA (tocilizumab)...
18 July 2011 | By Merck
The European Commission approved VICTRELIS™ (boceprevir)...
15 July 2011 | By Amgen
The European Commission has granted marketing authorization for XGEVA® (denosumab)...
14 July 2011 | By Novo Nordisk
Novo Nordisk has been granted approval by the European Commission for the new prefilled insulin pen – FlexTouch®...
14 July 2011 | By Bristol-Myers Squibb
The European Commission has approved YERVOY™ (ipilimumab)...
21 June 2011 | By Eli Lilly and Company
Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announced that the European Commission has granted marketing authorization to BYDUREON™...
7 June 2011 | By Biogen Idec
Biogen Idec announced that the European Commission has granted approval to AVONEX PEN...
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...